product summary
Loading...
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human Erythropoietin Quantikine IVD ELISA Kit
catalog :
DEP00
quantity :
1 Kit
price :
945 USD
more info or order :
citations: 73
Reference
Odunze U, Rustogi N, Devine P, Miller L, Pereira S, Vashist S, et al. RNA encoded peptide barcodes enable efficient in vivo screening of RNA delivery systems. Nucleic Acids Res. 2024;52:9384-9396 pubmed publisher
Lee Y, Jeong M, Lee G, Park J, Jung H, Im S, et al. Development of Lipid Nanoparticle Formulation for the Repeated Administration of mRNA Therapeutics. Biomater Res. 2024;28:0017 pubmed publisher
Toro L, Rojas V, Conejeros C, Ayala P, Parra Lucares A, Ahumada F, et al. A Combined Biomarker That Includes Plasma Fibroblast Growth Factor 23, Erythropoietin, and Klotho Predicts Short- and Long-Term Morbimortality and Development of Chronic Kidney Disease in Critical Care Patients with Sepsis: A Prospective Cohort. Biomolecules. 2023;13: pubmed publisher
Frise M, Holdsworth D, Johnson A, Chung Y, Curtis M, Cox P, et al. Abnormal whole-body energy metabolism in iron-deficient humans despite preserved skeletal muscle oxidative phosphorylation. Sci Rep. 2022;12:998 pubmed publisher
Cohen C, Coulon S, Bhukhai K, Neuraz A, Dussiot M, Fouquet G, et al. Erythrocytosis associated with IgA nephropathy. EBioMedicine. 2022;75:103785 pubmed publisher
Royal J, Eiken O, Keramidas M, McDonnell A, Mekjavic I. Heterogeneity of Hematological Response to Hypoxia and Short-Term or Medium-Term Bed Rest. Front Physiol. 2021;12:777611 pubmed publisher
Raslan A, Ciriza J, Ochoa de Retana A, Sanjuán M, Toprak M, Galvez Martín P, et al. Modulation of Conductivity of Alginate Hydrogels Containing Reduced Graphene Oxide through the Addition of Proteins. Pharmaceutics. 2021;13: pubmed publisher
Man M, Ganera C, Bărbuleț G, Krzysztofik M, Panaet A, Cucui A, et al. The Modifications of Haemoglobin, Erythropoietin Values and Running Performance While Training at Mountain vs. Hilltop vs. Seaside. Int J Environ Res Public Health. 2021;18: pubmed publisher
Riley R, Kashyap M, Billingsley M, White B, Alameh M, Bose S, et al. Ionizable lipid nanoparticles for in utero mRNA delivery. Sci Adv. 2021;7: pubmed publisher
Zanchi A, Burnier M, Muller M, Ghajarzadeh Wurzner A, Maillard M, Loncle N, et al. Acute and Chronic Effects of SGLT2 Inhibitor Empagliflozin on Renal Oxygenation and Blood Pressure Control in Nondiabetic Normotensive Subjects: A Randomized, Placebo-Controlled Trial. J Am Heart Assoc. 2020;9:e016173 pubmed publisher
Dhillon S, Wassink G, Lear C, Davidson J, Holford N, Gunn A, et al. The Effect of Size, Maturation, Global Asphyxia, Cerebral Ischemia, and Therapeutic Hypothermia on the Pharmacokinetics of High-Dose Recombinant Erythropoietin in Fetal Sheep. Int J Mol Sci. 2020;21: pubmed publisher
Davidovic S, Babić N, Jovanovic S, Barisić S, Grković D, Miljković A. Serum erythropoietin concentration and its correlation with stage of diabetic retinopathy. BMC Ophthalmol. 2019;19:227 pubmed publisher
Montero D, Haider T, Barthelmes J, Goetze J, Cantatore S, Sudano I, et al. Hypovolemia and reduced hemoglobin mass in patients with heart failure and preserved ejection fraction. Physiol Rep. 2019;7:e14222 pubmed publisher
Liefhebber J, Martier R, van der Zon T, Keskin S, Huseinovic A, Lubelski J, et al. In-Depth Characterization of a Mifepristone-Regulated Expression System for AAV5-Mediated Gene Therapy in the Liver. Mol Ther Methods Clin Dev. 2019;13:512-525 pubmed publisher
Montero D, Haider T, Barthelmes J, Goetze J, Cantatore S, Lundby C, et al. Age-dependent impairment of the erythropoietin response to reduced central venous pressure in HFpEF patients. Physiol Rep. 2019;7:e14021 pubmed publisher
Bhat K, Sandler K, Duhachek Muggy S, Alli C, Cheng F, Moatamed N, et al. Serum erythropoietin levels, breast cancer and breast cancer-initiating cells. Breast Cancer Res. 2019;21:17 pubmed publisher
Stoffel N, Lazrak M, Bellitir S, Mir N, Hamdouchi A, Barkat A, et al. The opposing effects of acute inflammation and iron deficiency anemia on serum hepcidin and iron absorption in young women. Haematologica. 2019;104:1143-1149 pubmed publisher
Saenz del Burgo L, Ciriza J, Espona Noguera A, Illa X, Cabruja E, Orive G, et al. 3D Printed porous polyamide macrocapsule combined with alginate microcapsules for safer cell-based therapies. Sci Rep. 2018;8:8512 pubmed publisher
Kwon M, Koo B, Kim D, Nam Y, Cui X, Kim N, et al. Generation of transgenic chickens expressing the human erythropoietin (hEPO) gene in an oviduct-specific manner: Production of transgenic chicken eggs containing human erythropoietin in egg whites. PLoS ONE. 2018;13:e0194721 pubmed publisher
Brunacci F, Rocha V, De Carli E, Esposito B, Ruano R, Colli C. Increased serum iron in preeclamptic women is likely due to low hepcidin levels. Nutr Res. 2018;53:32-39 pubmed publisher
Yanez Arteta M, Kjellman T, Bartesaghi S, Wallin S, Wu X, Kvist A, et al. Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles. Proc Natl Acad Sci U S A. 2018;115:E3351-E3360 pubmed publisher
Aachmann Andersen N, Christensen S, Lisbjerg K, Oturai P, Johansson P, Holstein Rathlou N, et al. Recombinant erythropoietin acutely decreases renal perfusion and decouples the renin-angiotensin-aldosterone system. Physiol Rep. 2018;6: pubmed publisher
Ferrannini E, Baldi S, Frascerra S, Astiarraga B, Barsotti E, Clerico A, et al. Renal Handling of Ketones in Response to Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes. Diabetes Care. 2017;40:771-776 pubmed publisher
Moraleda C, Aguilar R, Quintó L, Nhampossa T, Renom M, Nhabomba A, et al. Anaemia in hospitalised preschool children from a rural area in Mozambique: a case control study in search for aetiological agents. BMC Pediatr. 2017;17:63 pubmed publisher
Millot S, Delaby C, Moulouel B, Lefebvre T, Pilard N, Ducrot N, et al. Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model. Haematologica. 2017;102:260-270 pubmed publisher
Turnbull C, Rossi V, Santer P, Schwarz E, Stradling J, Petousi N, et al. Effect of OSA on hypoxic and inflammatory markers during CPAP withdrawal: Further evidence from three randomized control trials. Respirology. 2017;22:793-799 pubmed publisher
Rahmig S, Kronstein Wiedemann R, Fohgrub J, Kronstein N, Nevmerzhitskaya A, Bornhauser M, et al. Improved Human Erythropoiesis and Platelet Formation in Humanized NSGW41 Mice. Stem Cell Reports. 2016;7:591-601 pubmed publisher
Cristancho E, Riveros A, Sánchez A, Peñuela O, Böning D. Diurnal changes of arterial oxygen saturation and erythropoietin concentration in male and female highlanders. Physiol Rep. 2016;4: pubmed publisher
Derosa F, Guild B, Karve S, Smith L, Love K, Dorkin J, et al. Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system. Gene Ther. 2016;23:699-707 pubmed publisher
Rex T, Kasmala L, Bond W, de Lucas Cerrillo A, Wynn K, Lewin A. Erythropoietin Slows Photoreceptor Cell Death in a Mouse Model of Autosomal Dominant Retinitis Pigmentosa. PLoS ONE. 2016;11:e0157411 pubmed publisher
Keramidas M, Mekjavic I, Kolegard R, Chouker A, Strewe C, Eiken O. PlanHab: Hypoxia counteracts the erythropoietin suppression, but seems to exaggerate the plasma volume reduction induced by 3 weeks of bed rest. Physiol Rep. 2016;4: pubmed publisher
Valente M, Denis J, Grenier N, Arvers P, Foucher B, Desangles F, et al. Revisiting Biomarkers of Total-Body and Partial-Body Exposure in a Baboon Model of Irradiation. PLoS ONE. 2015;10:e0132194 pubmed publisher
Thess A, Grund S, Mui B, Hope M, Baumhof P, Fotin Mleczek M, et al. Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals. Mol Ther. 2015;23:1456-64 pubmed publisher
de Lucas Cerrillo A, Bond W, Rex T. Safety and angiogenic effects of systemic gene delivery of a modified erythropoietin. Gene Ther. 2015;22:365-73 pubmed publisher
Flamme I, Oehme F, Ellinghaus P, Jeske M, Keldenich J, Thuss U. Mimicking hypoxia to treat anemia: HIF-stabilizer BAY 85-3934 (Molidustat) stimulates erythropoietin production without hypertensive effects. PLoS ONE. 2014;9:e111838 pubmed publisher
Le Guiner C, Stieger K, Toromanoff A, Guilbaud M, Mendes Madeira A, Devaux M, et al. Transgene regulation using the tetracycline-inducible TetR-KRAB system after AAV-mediated gene transfer in rodents and nonhuman primates. PLoS ONE. 2014;9:e102538 pubmed publisher
Amanzada A, Goralczyk A, Reinhardt L, Moriconi F, Cameron S, Mihm S. Erythropoietin rs1617640 G allele associates with an attenuated rise of serum erythropoietin and a marked decline of hemoglobin in hepatitis C patients undergoing antiviral therapy. BMC Infect Dis. 2014;14:503 pubmed publisher
Mercadal L, Mercadel L, Metzger M, Haymann J, Thervet E, Boffa J, et al. The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease. PLoS ONE. 2014;9:e99781 pubmed publisher
Szygula Z, Lubkowska A, Giemza C, Skrzek A, Bryczkowska I, Dołęgowska B. Hematological parameters, and hematopoietic growth factors: EPO and IL-3 in response to whole-body cryostimulation (WBC) in military academy students. PLoS ONE. 2014;9:e93096 pubmed publisher
Wu S, Yang M, Kang K, Liou H, Lu D, Fu W, et al. Targeted delivery of erythropoietin by transcranial focused ultrasound for neuroprotection against ischemia/reperfusion-induced neuronal injury: a long-term and short-term study. PLoS ONE. 2014;9:e90107 pubmed publisher
Zhang X, Zhang W, Ma S, Desai A, Saraf S, Miasniakova G, et al. Hypoxic response contributes to altered gene expression and precapillary pulmonary hypertension in patients with sickle cell disease. Circulation. 2014;129:1650-8 pubmed publisher
Chen N, Wang W, Fauty S, Fang Y, Hamuro L, Hussain A, et al. The effect of the neonatal Fc receptor on human IgG biodistribution in mice. MAbs. 2014;6:502-8 pubmed publisher
Krautkrämer E, Grouls S, Hettwer D, Rafat N, Tönshoff B, Zeier M. Mobilization of circulating endothelial progenitor cells correlates with the clinical course of hantavirus disease. J Virol. 2014;88:483-9 pubmed publisher
Aksoy C, Guliyev A, Kilic E, Uckan D, Severcan F. Bone marrow mesenchymal stem cells in patients with beta thalassemia major: molecular analysis with attenuated total reflection-Fourier transform infrared spectroscopy study as a novel method. Stem Cells Dev. 2012;21:2000-11 pubmed publisher
Ni W, Le Guiner C, Gernoux G, Penaud Budloo M, Moullier P, Snyder R. Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: implications for gene doping. Gene Ther. 2011;18:709-18 pubmed publisher
Farha S, Asosingh K, Xu W, Sharp J, George D, COMHAIR S, et al. Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities. Blood. 2011;117:3485-93 pubmed publisher
Labonté L, Li Y, Yang L, Gillingham A, Halpenny M, Giulivi A, et al. Increased plasma EPO and MIP-1 alpha are associated with recruitment of vascular progenitors but not CD34(+) cells in autologous peripheral blood stem cell grafts. Exp Hematol. 2009;37:673-8 pubmed publisher
Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood. 2009;113:5277-86 pubmed publisher
Robach P, Recalcati S, Girelli D, Gelfi C, Aachmann Andersen N, Thomsen J, et al. Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin. Blood. 2009;113:6707-15 pubmed publisher
Liem Moolenaar M, Cerneus D, Molloy C, End D, Brown K, de Kam M, et al. Pharmacodynamics and pharmacokinetics of the novel thrombopoietin mimetic peptide RWJ-800088 in humans. Clin Pharmacol Ther. 2008;84:481-7 pubmed
Poulsen T, Andersen L, Steinbruchel D, Gøtze J, Jørgensen O, Olsen N. Two large preoperative doses of erythropoietin do not reduce the systemic inflammatory response to cardiac surgery. J Cardiothorac Vasc Anesth. 2009;23:316-23 pubmed publisher
Zimmermann M, Fucharoen S, Winichagoon P, Sirankapracha P, Zeder C, Gowachirapant S, et al. Iron metabolism in heterozygotes for hemoglobin E (HbE), alpha-thalassemia 1, or beta-thalassemia and in compound heterozygotes for HbE/beta-thalassemia. Am J Clin Nutr. 2008;88:1026-31 pubmed
Rawat R, Stoltzfus R, Ntozini R, Mutasa K, Iliff P, Humphrey J. Influence of inflammation as measured by alpha-1-acid glycoprotein on iron status indicators among HIV-positive postpartum Zimbabwean women. Eur J Clin Nutr. 2009;63:787-93 pubmed publisher
Klings E, Anton Bland D, Rosenman D, Princeton S, Odhiambo A, Li G, et al. Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: clinical characteristics and association with soluble adhesion molecule expression. Am J Hematol. 2008;83:547-53 pubmed publisher
Angelillo Scherrer A, Burnier L, Lambrechts D, Fish R, Tjwa M, Plaisance S, et al. Role of Gas6 in erythropoiesis and anemia in mice. J Clin Invest. 2008;118:583-96 pubmed publisher
Stieger K, Mendes Madeira A, Meur G, Weber M, Deschamps J, Nivard D, et al. Oral administration of doxycycline allows tight control of transgene expression: a key step towards gene therapy of retinal diseases. Gene Ther. 2007;14:1668-73 pubmed
Kissel C, Lehmann R, Assmus B, Aicher A, Honold J, Fischer Rasokat U, et al. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol. 2007;49:2341-9 pubmed
Rafat N, Hanusch C, Brinkkoetter P, Schulte J, Brade J, Zijlstra J, et al. Increased circulating endothelial progenitor cells in septic patients: correlation with survival. Crit Care Med. 2007;35:1677-84 pubmed
Sebestyen M, Hegge J, Noble M, Lewis D, Herweijer H, Wolff J. Progress toward a nonviral gene therapy protocol for the treatment of anemia. Hum Gene Ther. 2007;18:269-85 pubmed
Brettschneider J, Widl K, Schattauer D, Ludolph A, Tumani H. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis. Neurosci Lett. 2007;416:257-60 pubmed
Robach P, Cairo G, Gelfi C, Bernuzzi F, Pilegaard H, Vigano A, et al. Strong iron demand during hypoxia-induced erythropoiesis is associated with down-regulation of iron-related proteins and myoglobin in human skeletal muscle. Blood. 2007;109:4724-31 pubmed
Pontikoglou C, Liapakis G, Pyrovolaki K, Papadakis M, Bux J, Eliopoulos G, et al. Evidence for downregulation of erythropoietin receptor in bone marrow erythroid cells of patients with chronic idiopathic neutropenia. Exp Hematol. 2006;34:1312-22 pubmed
Claessens Y, Fontenay M, Pène F, Chiche J, Guesnu M, Hababou C, et al. Erythropoiesis abnormalities contribute to early-onset anemia in patients with septic shock. Am J Respir Crit Care Med. 2006;174:51-7 pubmed
Furstenberger G, von Moos R, Lucas R, Thurlimann B, Senn H, Hamacher J, et al. Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. Br J Cancer. 2006;94:524-31 pubmed
Stieger K, Le Meur G, Lasne F, Weber M, Deschamps J, Nivard D, et al. Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors. Mol Ther. 2006;13:967-75 pubmed
Zamudio S, Baumann M, Illsley N. Effects of chronic hypoxia in vivo on the expression of human placental glucose transporters. Placenta. 2006;27:49-55 pubmed
Premawardhena A, Fisher C, Olivieri N, de Silva S, Arambepola M, Perera W, et al. Haemoglobin E beta thalassaemia in Sri Lanka. Lancet. 2005;366:1467-70 pubmed
Rivera V, Gao G, Grant R, Schnell M, Zoltick P, Rozamus L, et al. Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. Blood. 2005;105:1424-30 pubmed
Danet G, Pan Y, Luongo J, Bonnet D, Simon M. Expansion of human SCID-repopulating cells under hypoxic conditions. J Clin Invest. 2003;112:126-35 pubmed
Andréasson B, Harrison C, Lindstedt G, Linch D, Kutti J. Monoclonal myelopoiesis and subnormal erythropoietin concentration are independent risk factors for thromboembolic complications in essential thrombocythemia. Blood. 2003;101:783 pubmed
Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med. 2002;8:495-505 pubmed
Favre D, Blouin V, Provost N, Spisek R, Porrot F, Bohl D, et al. Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus. J Virol. 2002;76:11605-11 pubmed
Capalbo S, Battista C, Delia M, Ciancio A, De Santis G, Dargenio M, et al. Evaluation of tumor necrosis factor-alpha and erythropoietin serum levels in B-cell chronic lymphocytic leukemia patients with anemia. Acta Haematol. 2002;108:84-9 pubmed
image
image 1 :
R&D Systems DEP00 image 1
Human Erythropoietin ELISA/Epo ELISA Benchtop Protocol
product information
brand :
R&D Systems
master code :
DEP00
SKU :
DEP00
product name :
Human Erythropoietin Quantikine IVD ELISA Kit
unit size :
1 Kit
seo description :
The Human Erythropoietin Quantikine IVD ELISA Kit from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human Erythropoietin/EPO in serum (100 ul), edta plasma (100 ul).
target :
Erythropoietin/EPO
category :
ELISAs
dilution :
ELISA
species :
Human
specificity :
Natural and recombinant human Epo
gene symbol :
EPO
kit type :
Solid Phase Sandwich ELISA
assay length :
4.5 hours (Benchtop Protocol) or 2.5 hours (Shaker Protocol)
elisaSampleTypes :
Serum (100 uL), EDTA Plasma (100 uL)
elisaRange :
2.50 - 200 mIU/mL (Serum, EDTA Plasma), 0.00 - 0 Not Assigned ()
top caption :
Human Erythropoietin ELISA/Epo ELISA Benchtop Protocol
applications :
ELISA
extended description :
For In Vitro Diagnostic Use
USD :
945 USD
product details :
The Quantikine« IVD Human Epo ELISA is designed to measure Epo levels in serum or plasma in less than 4.5 hours (or less than 2.5 hours using the shaker protocol) for the quantitative determination of erythropoietin (Epo) concentration in human serum and plasma as an aid in the diagnosis of anemia and polycythemia. For in vitro diagnostic use.
alt names :
ECYT5, EP, EPO, epoetin, erythropoietin, MGC138142, MVCD2
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.